Cargando…
Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic Challenge
BACKGROUND: Calcitonin gene related peptide (CGRP) plays a key role in the pathophysiology of migraine and is therefore considered a potential biomarker for primary headache disorders. The challenge remaining is establishing standardized protocols for its assessment in various extracellular compartm...
Autores principales: | Frank, Florian, Kaltseis, Katharina, Messlinger, Karl, Broessner, Gregor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367467/ https://www.ncbi.nlm.nih.gov/pubmed/35968307 http://dx.doi.org/10.3389/fneur.2022.925748 |
Ejemplares similares
-
Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1)
por: Kaltseis, Katharina, et al.
Publicado: (2022) -
CGRP measurements in human plasma – a methodological study
por: Messlinger, Karl, et al.
Publicado: (2021) -
Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series
por: Kaltseis, Katharina, et al.
Publicado: (2023) -
Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review
por: Kaltseis, Katharina, et al.
Publicado: (2022) -
Migraine and aura triggered by normobaric hypoxia
por: Frank, Florian, et al.
Publicado: (2020)